Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children

• Main Authors: Wanatpreeya Phongsamart, Virat Sirisanthana, Orasri Wittawatmongkol, Alan Maleesatharn, Tavitiya Sudjaritruk, Pimpannada Chearskul, Linda Aurpibul, Thira Sirisanthana, Kulkanya Chokephaibulkit
• Format: Journal
• Published: 2018
• Subjects: Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine; Veterinary
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=82455192719&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/49673
• Institution: Chiang Mai University

To evaluate the immunogenicity and safety of the monovalent pandemic influenza A (H1N1) 2009 (pH1N1) vaccine in HIV-infected Thai children, 2 doses, 28days apart, of non-adjuvant monovalent pH1N1 vaccine (Panenza®by Sanofi Pasteur, 15μg/dose) provided by the National Health Promotion Program of the...